These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38876301)

  • 1. Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
    Yang Y; Xu L; Zhang S; Yao L; Ding Y; Li W; Chen X
    J Biol Chem; 2024 Jul; 300(7):107468. PubMed ID: 38876301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Embryonic Stem Cell-Specific NuRD Complex Functions through Interaction with WDR5.
    Ee LS; McCannell KN; Tang Y; Fernandes N; Hardy WR; Green MR; Chu F; Fazzio TG
    Stem Cell Reports; 2017 Jun; 8(6):1488-1496. PubMed ID: 28528697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
    Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
    J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
    Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
    J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.
    Patel A; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32158-61. PubMed ID: 18829459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.
    Imran A; Moyer BS; Canning AJ; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
    Biochem J; 2021 Jun; 478(11):2145-2161. PubMed ID: 34032265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.
    Huang X; Zhang C; Shang X; Chen Y; Xiao Q; Wei Z; Wang G; Zhen X; Xu G; Min J; Shen S; Liu Y
    Cell Death Dis; 2024 May; 15(5):335. PubMed ID: 38744853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.
    Zhang P; Lee H; Brunzelle JS; Couture JF
    Nucleic Acids Res; 2012 May; 40(9):4237-46. PubMed ID: 22266653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
    Shinsky SA; Cosgrove MS
    J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity.
    Aho ER; Wang J; Gogliotti RD; Howard GC; Phan J; Acharya P; Macdonald JD; Cheng K; Lorey SL; Lu B; Wenzel S; Foshage AM; Alvarado J; Wang F; Shaw JG; Zhao B; Weissmiller AM; Thomas LR; Vakoc CR; Hall MD; Hiebert SW; Liu Q; Stauffer SR; Fesik SW; Tansey WP
    Cell Rep; 2019 Mar; 26(11):2916-2928.e13. PubMed ID: 30865883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WIN site inhibition disrupts a subset of WDR5 function.
    Siladi AJ; Wang J; Florian AC; Thomas LR; Creighton JH; Matlock BK; Flaherty DK; Lorey SL; Howard GC; Fesik SW; Weissmiller AM; Liu Q; Tansey WP
    Sci Rep; 2022 Feb; 12(1):1848. PubMed ID: 35115608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of WIN site inhibitor on the WDR5 interactome.
    Guarnaccia AD; Rose KL; Wang J; Zhao B; Popay TM; Wang CE; Guerrazzi K; Hill S; Woodley CM; Hansen TJ; Lorey SL; Shaw JG; Payne WG; Weissmiller AM; Olejniczak ET; Fesik SW; Liu Q; Tansey WP
    Cell Rep; 2021 Jan; 34(3):108636. PubMed ID: 33472061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex.
    Patel A; Vought VE; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32162-75. PubMed ID: 18829457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDR5 is a conserved regulator of protein synthesis gene expression.
    Bryan AF; Wang J; Howard GC; Guarnaccia AD; Woodley CM; Aho ER; Rellinger EJ; Matlock BK; Flaherty DK; Lorey SL; Chung DH; Fesik SW; Liu Q; Weissmiller AM; Tansey WP
    Nucleic Acids Res; 2020 Apr; 48(6):2924-2941. PubMed ID: 31996893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.
    Ding J; Li G; Liu H; Liu L; Lin Y; Gao J; Zhou G; Shen L; Zhao M; Yu Y; Guo W; Hommel U; Ottl J; Blank J; Aubin N; Wei Y; He H; Sage DR; Atadja PW; Li E; Jain RK; Tallarico JA; Canham SM; Chiang YL; Wang H
    ACS Chem Biol; 2023 Jan; 18(1):34-40. PubMed ID: 36594833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Binary Arginine Methylation Switch on Histone H3 Arginine 2 Regulates Its Interaction with WDR5.
    Lorton BM; Harijan RK; Burgos ES; Bonanno JB; Almo SC; Shechter D
    Biochemistry; 2020 Oct; 59(39):3696-3708. PubMed ID: 32207970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
    Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
    mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.
    Tian J; Teuscher KB; Aho ER; Alvarado JR; Mills JJ; Meyers KM; Gogliotti RD; Han C; Macdonald JD; Sai J; Shaw JG; Sensintaffar JL; Zhao B; Rietz TA; Thomas LR; Payne WG; Moore WJ; Stott GM; Kondo J; Inoue M; Coffey RJ; Tansey WP; Stauffer SR; Lee T; Fesik SW
    J Med Chem; 2020 Jan; 63(2):656-675. PubMed ID: 31858797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis.
    Qin Y; Dong X; Lu M; Jing L; Chen Q; Guan F; Xiang Z; Huang J; Yang C; He X; Qu J; Yang Z
    Cancer Lett; 2024 Jul; 593():216952. PubMed ID: 38750719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models.
    Teuscher KB; Chowdhury S; Meyers KM; Tian J; Sai J; Van Meveren M; South TM; Sensintaffar JL; Rietz TA; Goswami S; Wang J; Grieb BC; Lorey SL; Howard GC; Liu Q; Moore WJ; Stott GM; Tansey WP; Lee T; Fesik SW
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2211297120. PubMed ID: 36574664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.